Abbott LaboratoriesABT
Diagnostics · NYSE · USA
$98.49
Down 0.2% todayClose
Down 21.2% this year but +4.6% since June 26, behind the life science sector at +10.7%. Abbott Laboratories supplies 2 mapped companies.
Supply chain
2 customersCustomers 2
About Abbott Laboratories
In vitro diagnostics, medical devices that include the Libre glucose sensors, nutrition products and generic medicines: Abbott runs all four.
Theme exposure
Same segment: Diagnostics
Tests, imaging and assays that support clinical decision-making. Segment 6 of 8 in the Medicine, pharma & life science value chain.
Compare ABT
Side by side with the largest companies in the same segment.
See where Abbott Laboratories sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.
Open the Life science value chain →